Gadoquatrane
Gadoquatrane is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand name including Ambelvist. Available dosage form: injection.
Drug Details
- Generic Name
- Gadoquatrane
- Brand Names
- Ambelvist
- Application Number
- NDA219627
- Sponsor
- Bayer HealthCare Pharmaceuticals Inc.
- NDC Codes
- 12
- Dosage Forms
- INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- GADOQUATRANE
Indications and Usage
1 INDICATIONS AND USAGE AMBELVIST is indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in: the central nervous system (brain, spine, and associated tissues) the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system) AMBELVIST is a gadolinium-based contrast agent indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in: the central nervous system (brain, spine, and associated tissues) the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system) ( 1 )